Veo

Veo is a biotechnology company focused on the discovery and development of novel small molecule therapeutics for the treatment of retinal diseases and other ophthalmological conditions. The company utilizes its proprietary Veo Discovery Platform to identify and optimize drug candidates that target specific biological pathways involved in vision loss. By leveraging advanced screening and computational techniques, Veo aims to address significant unmet needs in the field of ophthalmology. The company's pipeline is currently in the pre-clinical stage, with a focus on developing treatments that can be delivered effectively to the eye.